Your browser doesn't support javascript.
loading
What does a non-response to induction chemotherapy imply in high-risk medulloblastomas?
Adelon, Jihane; Dufour, Christelle; Foulon, Stéphanie; Masliah Planchon, Julien; Meyronnet, David; Bourdeaut, Franck; Palenzuela, Gilles; Fouyssac, Fanny; Raimbault, Sandra; De Carli, Emilie; Klein, Sébastien; Pagnier, Anne; Bertozzi, Anne-Isabelle; Rome, Angélique; David, Audrey; Chabaud, Sylvie; Faure-Conter, Cécile.
Afiliação
  • Adelon J; Department of Pediatrics, Institut d'Hématologie et d'Oncologie pédiatrique, 1 Place Professeur Joseph Renaut, 69008, Lyon, France. jihane.adelon@gmail.com.
  • Dufour C; Department of Pediatric and Adolescent Oncology, Gustave Roussy Institute, Villejuif, France.
  • Foulon S; Biostatistics and Methodology Unit, Department of Clinical Research and Investigation, Gustave Roussy Institute, Villejuif, France.
  • Masliah Planchon J; INSERM U830, Laboratory of Translational Research in Pediatric Oncology, SIREDO Pediatric Oncology Center, Curie Institute, Paris, France.
  • Meyronnet D; Department of Neuropathology, Institut de Pathologie Est, Hospices civils de Lyon, Lyon, France.
  • Bourdeaut F; SIREDO Pediatric Oncology Center, Curie Institute, Paris, France.
  • Palenzuela G; Department of Pediatric Hematology-Oncology, Centre Hospitalo-Universitaire de Montpellier, Montpellier, France.
  • Fouyssac F; Department of Pediatric Oncology, Children's Hospital, Nancy, France.
  • Raimbault S; Pediatric Oncology Unit, Oscar Lambret Comprehensive Cancer Center, Lille, France.
  • De Carli E; Department of Pediatric Oncology, University Hospital, Angers, France.
  • Klein S; Department of Pediatric Hematology-Oncology, University Hospital, Besançon, France.
  • Pagnier A; Department of Pediatric Immunohematology and Oncology, University Hospital, Grenoble, France.
  • Bertozzi AI; Department of Pediatric Onco-Hematology, CHU Toulouse, France.
  • Rome A; Department of Pediatric Hematology and Oncology, La Timone Children's Hospital, Marseille, France.
  • David A; Department of Pediatric Hematology and Oncology Unit, University Hospital of Saint-Étienne, Saint-Étienne, France.
  • Chabaud S; Clinical Research and Innovation Department, Léon Bérard Cancer Centre, Biostatistics Unit, Lyon, France.
  • Faure-Conter C; Department of Pediatrics, Institut d'Hématologie et d'Oncologie pédiatrique, 1 Place Professeur Joseph Renaut, 69008, Lyon, France.
J Neurooncol ; 153(3): 425-440, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34076831
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurooncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cerebelares / Meduloblastoma Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Neurooncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França